Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-04-28

Clinical Trial Update: Phenol Neurolysis of Genicular Nerves for Chronic Knee Pain [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial on phenol neurolysis of genicular nerves for chronic knee pain was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Northwestern University | Conditions: Pain, Chronic | Phase 4 | Status: WITHDRAWN